A Treatment Effectiveness Study Among SLE Patients Receiving Anifrolumab in Routine Clinical Practice

Active, not recruitingOBSERVATIONAL
Enrollment

551

Participants

Timeline

Start Date

February 27, 2023

Primary Completion Date

December 30, 2030

Study Completion Date

December 30, 2030

Conditions
Systemic Lupus Erythematosus
Interventions
OTHER

None (Observational study)

Not Applicable since Observational Study

Trial Locations (79)

149

Research Site, Rome

161

Research Site, Roma

168

Research Site, Roma

1180

Research Site, Vienna

3000

Research Site, Leuven

4000

Research Site, Liège

4020

Research Site, Linz

6000

Research Site, Nice

6020

Research Site, Innsbruck

7272

Research Site, Dubai

8000

Research Site, Bruges

9042

Research Site, Cagliari

9300

Research Site, Aalst

10117

Research Site, Berlin

10126

Research Site, Turin

14033

Research Site, Paris

15208

Research Site, Tiberias

17489

Research Site, Greifwald

17493

Research Site, Greifswald

18101

Research Site, Afula

18288

Research Site, Danderyd

20122

Research Site, Milan

Research Site, Milan

20132

Research Site, Milan

21079

Research Site, Dijon

23562

Research Site, Schleswig-Holstein

24576

Research Site, Bad Bramstedt

25100

Research Site, Brescia

29609

Research Site, Finist Re

33076

Research Site, Bordeaux

33100

Research Site, Udine

38043

Research Site, Grenoble

39104

Research Site, Magdeburg

40225

Research Site, D Sseldorf

44093

Research Site, Nantes

44124

Research Site, Cona

44649

Research Site, Herne

50134

Research Site, Florence

51149

Research Site, Cologne

52621

Research Site, Ramat Gan

55131

Research Site, Mainz A. Rhein

56126

Research Site, Pisa

59037

Research Site, Lille

60126

Research Site, Ancona

63000

Research Site, Clermont-Ferrand

67098

Research Site, Strasbourg

69003

Research Site, Bouches-du-Rh Ne

69120

Research Site, Heidelberg

Research Site, Heidelberg

70124

Research Site, Bari

70185

Research Site, Örebro

72772

Research Site, Sharjah city

75013

Research Site, Paris

75014

Research Site, Paris

75020

Research Site, Paris

75475

Research Site, Paris

76230

Research Site, Seine-Maritime

80131

Research Site, Napoli

81925

Research Site, Munich

91054

Research Site, Erlangen

91120

Research Site, Jerusalem

97261

Research Site, FORT de France Cedex

97405

Research Site, Saint-Denis

3109601

Research Site, Haifa

3436212

Research Site, Haifa

4428164

Research Site, Kfar Saba

5211401

Research Site, Tel Hashomer

6423906

Research Site, Tel Aviv

T2N 4N1

Research Site, Calgary

RR149

Research Site, Winnipeg

L8N 3Z5

Research Site, Hamilton

L3V 1T5

Research Site, Orillia

M5T 2S9

Research Site, Toronto

G5L 5T1

Research Site, Rimouski

J1G 2E8

Research Site, Sherbrooke

G1V 4G2

Research Site, Ste-Foy

171 76

Research Site, Stockholm

Unknown

Research Site, Dubai

Research Site, Abu Dhabi

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Parexel

INDUSTRY

lead

AstraZeneca

INDUSTRY